Stock BIBCL6 BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Bharat Immunologicals & Biologicals Corporation Limited

Equities

BIBCL6

INE994B01014

Market Closed - Bombay S.E.
Other stock markets
 11:18:58 24/05/2024 BST 		5-day change 1st Jan Change
31.02 INR -1.02% Intraday chart for Bharat Immunologicals & Biologicals Corporation Limited -0.83% -12.25%
2023 Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
2023 Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
CI
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the Full Year Ended March 31, 2023
CI
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
CI
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
CI
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
CI
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the Third Quarter Ended December 31, 2021
CI
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the Second Quarter Ended September 30, 2021
CI
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the First Quarter Ended June 30, 2021
CI
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the Full Year Ended March 31, 2021
CI
Bharat Immunologicals & Biologicals : to Receive Indian Government Funding for COVID Vaccine Production
MT
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020
CI
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020
CI
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the Full Year Ended March 31, 2020
CI
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the Third Quarter Ended December 31, 2019
CI
Bharat Immunologicals & Biologicals Corp. Ltd. Reports Earnings Results for the Second Quarter Ended September 30, 2019
CI
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the First Quarter Ended June 30, 2019
CI
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2019
CI
Bharat Immunologicals & Biologicals Corp. Ltd. Reports Earnings Results for the Third Quarter Ended December 31, 2018
CI
Bharat Immunologicals & Biologicals Corporation Limited Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended September 30, 2018
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BIBCL6 Stock
  4. News Bharat Immunologicals & Biologicals Corporation Limited
  5. Highlights